Cellular Origins

Cellular Origins is a UK-based biotechnology company focused on robotic automation solutions for the manufacturing of cell and gene therapies (CGTs).

Established in 2022 as a spin-out from TTP plc, the company is headquartered at the TTP Campus in Melbourn, Cambridgeshire. Led by CEO Dr. Edwin Stone, Cellular Origins aims to industrialize advanced therapy production through intelligent automation, enabling faster access to therapies for patients. The company's flagship product is the Constellation® ecosystem, a mobile robotic automation platform designed for scalable and efficient manufacturing. It integrates mobile robotics and AI with bioprocess instruments, addressing the challenges of scaling CGTs. Cellular Origins also offers consulting services, workflow automation, and various business models, including hardware sales and subscriptions. The company serves therapeutic developers and Contract Development and Manufacturing Organizations (CDMOs), partnering with industry leaders like Johnson & Johnson, Cytiva, and Thermo Fisher Scientific to enhance manufacturing capabilities in the life sciences sector.